Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin alone versus colistin plus meropenem for carbapenem-resistant Gram-negative infections
2012-004819-31Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Gram-negative bacterial infection and bacterial disease comparing Colistin alone with Colistin plus meropenem (2 arms). Primary endpoint: Clinical success at day 14. Started Oct 2012; status: active.
02
Drugs
colistinmeropenem
03
Conditions
Gram-negative bacterial infectionbacterial disease
Beyond the preview
Go deeper on 2012-004819-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004819-31.